“Glycemic Outcomes Of Dapagliflozin, Glimepiride, And Sitagliptin As Add-On Therapy To Metformin In Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study”. The Review of Diabetic Studies (September 14, 2025): 693–700. Accessed October 7, 2025. https://www.diabeticstudies.org/index.php/RDS/article/view/628.